PTH and neutropenia: Two subjects experienced SAEs, one administered TransCon PTH 12 μg PTH(1‐34)/day developed neutropenia in the setting of viral pharyngitis requiring brief hospitalization and one administered placebo developed catheter‐site phlebitis; neither SAE was assessed to be related to study drug and both resolved without sequelae.